CDNA EBITDA Growth
Caredx Inc · EBITDA Growth
CDNA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported159.12%period ending
CDNA TTM EBITDA YoY % (369.59% → 159.12%)
Year-over-year change
High-resolution chart · PNG
CDNA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 159.1199% | |
| 127.3441% | |
| 83.7731% | |
| 42.6907% | |
| 46.846% | |
| 71.7527% | |
| 63.6883% | |
| 54.2986% | |
| 25.7313% | |
| -13.8147% | |
| -31.1737% | |
| -20.9634% | |
| -17.1255% | |
| -65.6633% | |
| -199.4729% | |
| -769.4096% | |
| -3,553.5801% | |
| -1,218.737% | |
| -146.1265% | |
| 40.0882% | |
| 110.058% | |
| 84.2462% | |
| 57.0151% | |
| 33.5632% | |
| -18.5515% | |
| -58.4445% | |
| -67.2886% | |
| -52.4573% | |
| 35.9279% | |
| 42.4255% | |
| 43.6639% | |
| 47.5148% | |
| -72.8861% | |
| -13.8655% | |
| 11.0239% | |
| 4.1641% | |
| 46.0477% | |
| 6.1194% | |
| -109.607% | |
| -261.427% | |
| -668.561% | |
| -2,849.6855% | |
| -2,167.8776% | |
| -1,282.4859% | |
| -4,112% | |
| -400% | |
| 369.5876% |